Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial.
Lancet
; 404(10451): 433, 2024 Aug 03.
Article
in En
| MEDLINE
| ID: mdl-39097393
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purpura, Thrombocytopenic, Idiopathic
Limits:
Humans
Language:
En
Journal:
Lancet
Year:
2024
Type:
Article